Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NEC America :
  the Nasdaq Stock Market (nasdaq: NDAQ - news - people ) extended the company's filing deadline until Sept. 25. The company noted that Nasdaq may suspend its American Depositary Receipts and remove them from trading.

The company's ADRs represent about 2.9 percent of its total issued shares.

The company said it remains in compliance with the disclosure rules of the Tokyo Stock Exchange and the Securities and Exchange Law of Japan.

Share
New Message
Please login to post a reply